Sign in

CIK 0001158780

  • Non-accelerated filer
  • Smaller reporting company
Ticker
PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
NV
Entity type
Operating
EIN
980351734
Phone
+972 747107171
Business address
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, Israel
Former names
PLURISTEM THERAPEUTICS INC, PLURISTEM LIFE SYSTEMS INC, AI SOFTWARE INC
  1. 4 Grant or award Director acquired 65,000 shares (grant or award)
  2. 4 Grant or award Director acquired 50,000 shares (grant or award)
  3. 4 Grant or award Director acquired 35,000 shares (grant or award)
  4. 4 Grant or award Director acquired 35,000 shares (grant or award)
  5. 4 Grant or award Director acquired 50,000 shares (grant or award)
  6. 4 Open-market sale Director sold 67,244 shares at an average $3.27 ($219,883)
  7. 4 Open-market sale Director sold 52,000 shares at an average $3.07 ($159,891)
  8. 4 Grant or award Director acquired 85,000 shares (grant or award)
  9. 4 Grant or award Director acquired 50,000 shares (grant or award)
  10. 4 Grant or award Director acquired 50,000 shares (grant or award)
  11. 4 Grant or award Director acquired 85,000 shares (grant or award)
  12. 4 Grant or award Director acquired 50,000 shares (grant or award)
  13. 4 Grant or award Director acquired 50,000 shares (grant or award)
  14. 4 Grant or award Director acquired 85,000 shares (grant or award)
  15. 4 Grant or award CEO & Chairman acquired 350,000 shares (grant or award)
  16. 4 Grant or award CFO, Executive Vice President acquired 250,000 shares (grant or award)
  17. 4 Open-market buy Director bought 63,902 shares at an average $3.04 ($194,206)
  18. 4 Exercise or conversion Director acquired 27,500 shares (option exercise)
  19. 4 Open-market sale CEO & Chairman sold 33,853 shares at $5.00 ($169,265)
  20. 4 Open-market sale Chief Financial Officer sold 16,927 shares at $5.00 ($84,635)

Page 10 of 18 · 352 filings